Does MEPOLIZUMAB Cause Hypercholesterolaemia? 538 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 538 reports of Hypercholesterolaemia have been filed in association with MEPOLIZUMAB (Nucala). This represents 1.3% of all adverse event reports for MEPOLIZUMAB.
538
Reports of Hypercholesterolaemia with MEPOLIZUMAB
1.3%
of all MEPOLIZUMAB reports
491
Deaths
451
Hospitalizations
How Dangerous Is Hypercholesterolaemia From MEPOLIZUMAB?
Of the 538 reports, 491 (91.3%) resulted in death, 451 (83.8%) required hospitalization, and 420 (78.1%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 538 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which MEPOLIZUMAB Alternatives Have Lower Hypercholesterolaemia Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE